The Patent Finder

Carmot Therapeutics Inc.

Also on record
Records under this name other than the patents Carmot Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Back to Carmot Therapeutics Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,572,374N-CYANO-7-Azanorbornane Derivatives and Uses Thereof
now held by Amgen Inc.
In force
 · High confidence
In forceHigh confidence
17/586,751GPCR Receptor Agonists, Pharmaceutical Compositions Comprising the Same, and Methods for Their Use
Abandoned
Abandoned Nov 7, 2023
AbandonedAbandoned Nov 7, 2023
17/736,070Benzimidazoyl GLP-1 Receptor Agonists, Pharmaceutical Compositions Comprising the Same, and Methods for Their Use
Abandoned
Abandoned Apr 25, 2025
AbandonedAbandoned Apr 25, 2025
18/087,063Modulators of G-Protein Coupled Receptors
Abandoned
Abandoned Mar 27, 2025
AbandonedAbandoned Mar 27, 2025
18/240,763GLP-1 Receptor Agonists, Pharmaceutical Compositions Comprising the Same, and Methods for Their Use
Abandoned
Abandoned Apr 15, 2024
AbandonedAbandoned Apr 15, 2024
18/262,956GPCR Receptor Agonists, Pharmaceutical Compositions Comprising the Same, and Methods for Their Use
Abandoned
Abandoned May 7, 2025
AbandonedAbandoned May 7, 2025
18/558,647Benzimidazoyl GLP-1 Receptor Agonists, Pharmaceutical Compositions Comprising the Same, and Methods for Their Use
Abandoned
Abandoned Aug 25, 2026
AbandonedAbandoned Aug 25, 2026
18/632,736GPCR Receptor Agonists, Pharmaceutical Compositions Comprising the Same, and Methods for Their Use
Abandoned
Abandoned May 7, 2025
AbandonedAbandoned May 7, 2025
18/644,041Treatment of Diabetes Mellitus
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/670,592Treatment of Adults With Overweight or Obesity With or Without Weight-Related Comorbidities
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
10 of 19 records shown.
Pro members see all 19.
Pro members: see all 19 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited